Flurandrenolide

氟氢缩松

Report date: 2023/06/27 20:00:33
NME

Base Information

Drug NameFlurandrenolide
Drug Alias Name丙酮缩氟氢羟龙丙酮缩氟羟龙氟缩酮氢可松Cordran
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsSkin Diseases
Global Approved IndicationsSkin Diseases
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1963/03/19
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAlmirall Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIna Pharmaceutics Inc
Active IndicationsN/A
Inactive IndicationsSkin Diseases

Other Information

ATC CodeD07AC07